You are here

Article info

Article menu
Basic tumor immunology
Original research
PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy

Authors

  • Yiqi Xu Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, People's Republic of ChinaDepartment of Maxillofacial and Otorhinolaryngology Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China PubMed articlesGoogle scholar articles
  • Zhenyue Gao Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, People's Republic of ChinaDepartment of Maxillofacial and Otorhinolaryngology Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China PubMed articlesGoogle scholar articles
  • Ruxin Hu Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, People's Republic of China PubMed articlesGoogle scholar articles
  • Yuqing Wang Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, People's Republic of China PubMed articlesGoogle scholar articles
  • Yuhong Wang Department of Genetics, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, People's Republic of China PubMed articlesGoogle scholar articles
  • Zheng Su Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, People's Republic of China PubMed articlesGoogle scholar articles
  • Xiaoyue Zhang Department of Maxillofacial and Otorhinolaryngology Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China PubMed articlesGoogle scholar articles
  • Jingxuan Yang Department of Medicine, Department of Surgery, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA PubMed articlesGoogle scholar articles
  • Mei Mei Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, People's Republic of China PubMed articlesGoogle scholar articles
  • Yu Ren Department of Genetics, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, People's Republic of China PubMed articlesGoogle scholar articles
  • Min Li Department of Medicine, Department of Surgery, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA PubMed articlesGoogle scholar articles
  • Xuan Zhou Department of Maxillofacial and Otorhinolaryngology Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China PubMed articlesGoogle scholar articles

Citation

Xu Y, Gao Z, Hu R, et al
PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy
Journal for ImmunoTherapy of Cancer 2021;9:e002699. doi: 10.1136/jitc-2021-002699
Online issue publication 
June 27, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.